Gene therapy biotech Affinia Therapeutics aims to go public, files for a US$100 million IPO by Editor | Jan 6, 2022 | Hospitals, LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0 USA – Affinia Therapeutics, a preclinical biotech developing novel gene therapies for rare... Read More